(Q51494744)

English

A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies

scientific article published in July 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16842477

A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16842477

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

Hertzel C. Gerstein

1

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16842477

author name string

Yale JF

2

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16842477

Harris SB

3

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16842477

Issa M

4

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16842477

Stewart JA

5

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16842477

Dempsey E

6

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16842477

publication date

1 July 2006

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16842477

Diabetic Medicine

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16842477

23

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16842477

7

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16842477

736-742

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16842477

Non-esterified fatty acids are deleterious for human pancreatic islet function at physiological glucose concentration.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01881.X

21 January 2018

Metabolic modulation of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01881.X

21 January 2018

Metabolic approaches to the treatment of ischemic heart disease: the clinicians' perspective

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01881.X

21 January 2018

Metabolic abnormalities in the diabetic heart

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01881.X

21 January 2018

Is insulin an endogenous cardioprotector?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01881.X

21 January 2018

Insulin: an endogenous cardioprotector

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01881.X

21 January 2018

Insulin therapy improves endothelial function in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01881.X

21 January 2018

The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01881.X

21 January 2018

Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01881.X

21 January 2018

Intensive Insulin Therapy Exerts Antiinflammatory Effects in Critically Ill Patients and Counteracts the Adverse Effect of Low Mannose-Binding Lectin Levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2006.01881.X

21 January 2018

Identifiers

10.1111/J.1464-5491.2006.01881.X

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16842477

release_22ilmf4brvazpg4ae6boi3ue6y

1 reference

https://api.fatcat.wiki/v0/release/22ilmf4brvazpg4ae6boi3ue6y

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/16842477

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51494744&oldid=1844299259"